Business Services Global On demand · 24-48h

Global Biomarker Discovery Outsourcing Services Market Strategic Research Report

Global Biomarker Discovery Outsourcing Services Market Strat…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Biomarker Discovery Outsourcing Services Market
$13.82B2025
14.1%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Predictive biomarkers, Safety biomarkers, Prognostic biomarkers, Others

By Application: Biotechnology Company, Pharmaceutical Company, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Laboratory Corporation of America Holdings, GHO Capital, ICON plc, Agilent, Proteome Sciences, Charles River Laboratories., Eurofins Scientific, Celerion, Evotec, Parexel International (MA) Corporation

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 90 pages
Market size 2025
$13.82B
Billion USD
Forecast CAGR
14.1%
2025-2032
Forecast 2032
$34.8B
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global Biomarker Discovery Outsourcing Services market size is predicted to grow from US$ 13,820 million in 2025 to US$ 34,250 million in 2032; it is expected to grow at a CAGR of 14.1% from 2026 to 2032.

Biomarker discovery outsourcing services refer to the practice of contracting external organizations or service providers to conduct research and analysis aimed at identifying and validating biomarkers. Biomarkers are measurable indicators that can be used to assess various biological processes, disease conditions, or responses to treatment. Outsourcing biomarker discovery services allows companies, research institutions, or pharmaceutical organizations to leverage the expertise and capabilities of specialized service providers for this specific aspect of their research.

Biomarker discovery is increasingly adopting multi-omics approaches, which involve analyzing multiple biological data types such as genomics, transcriptomics, proteomics, and metabolomics. Outsourcing services are incorporating integrated analyses to provide a more comprehensive understanding of biomarker signatures.

This report presents a comprehensive overview of the global Biomarker Discovery Outsourcing Services market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Predictive biomarkers
  • Safety biomarkers
  • Prognostic biomarkers
  • Others

Segment by Application

  • Biotechnology Company
  • Pharmaceutical Company
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Biomarker Discovery Outsourcing Services market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Biotechnology Company, Pharmaceutical Company, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Biomarker Discovery Outsourcing Services Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 14.1%
Regional growth momentum
Market share by segment
Key metrics
Base value
$13.82B
2025
Forecast
$34.8B
2032
CAGR
14.1%
2025–2032
Regiones
5
global
Key companies
Laboratory Corporation of America HoldingsGHO CapitalICON plcAgilentProteome SciencesCharles River Laboratories.Eurofins ScientificCelerion
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Predictive biomarkersSafety biomarkersPrognostic biomarkersOthers
By Application
Biotechnology CompanyPharmaceutical CompanyOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Predictive biomarkers
  • 3.1.3 Safety biomarkers
  • 3.1.4 Prognostic biomarkers
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Biotechnology Company
  • 4.1.3 Pharmaceutical Company
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Laboratory Corporation of America Holdings
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 GHO Capital
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 ICON plc
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Agilent
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Proteome Sciences
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Charles River Laboratories.
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Eurofins Scientific
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Celerion
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Evotec
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Parexel International (MA) Corporation
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Biomarker Discovery Outsourcing Services market size?
The global Biomarker Discovery Outsourcing Services market is estimated at US$ 13.82 billion in 2025 (base year) and is projected to reach US$ 34.25 billion by 2032.
What growth rate is expected for the Biomarker Discovery Outsourcing Services market through 2032?
The market is expected to grow at a CAGR of 14.1% from 2026 to 2032, expanding from US$ 13.82 billion in 2025 to US$ 34.25 billion in 2032, roughly 2.5 times its base-year value.
How is Biomarker Discovery Outsourcing Services defined?
Biomarker discovery outsourcing services refer to the practice of contracting external organizations or service providers to conduct research and analysis aimed at identifying and validating biomarkers. Biomarkers are measurable indicators that can be used to assess various biological processes, disease conditions, or responses to treatment.
What are the main segments of the Biomarker Discovery Outsourcing Services market by type?
By type, the market is segmented into Predictive biomarkers, Safety biomarkers, Prognostic biomarkers and Others.
Which applications drive demand in the Biomarker Discovery Outsourcing Services market?
Key applications covered include Biotechnology Company, Pharmaceutical Company and Others.
Who are the key players in the Biomarker Discovery Outsourcing Services market?
Key players profiled include Laboratory Corporation of America Holdings, GHO Capital, ICON plc, Agilent, Proteome Sciences, Charles River Laboratories., Eurofins Scientific and Celerion, among 10 companies covered in total.
Which regions and countries are covered for Biomarker Discovery Outsourcing Services?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Biomarker Discovery Outsourcing Services market report?
The report is intended for manufacturers and solution providers, distributors and end users in Biotechnology Company, Pharmaceutical Company and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Biomarker Discovery Outsourcing Services market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.